Author:
Coruzzi G.,Adami M.,Pozzoli C.,Buschauer A.,Bertaccini G.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Coruzzi G, Adami M, Pozzoli C, Poli E, Bertaccini G. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors. Pharmacology 1994;48:69–76.
2. Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, Mylek ME, Parsons ME, Smith IR, Young RC. Zolantidine (SKF 95282) is a potent selective brain-penetrating histamine H2 receptor antagonist. Br J Pharmacol 1988;93:69–78.
3. Shankley NP, Black JW, Ganellin CR, Mitchell RC. Correlation between log POCT/H2O and pkB estimates for a series of muscarinic and histamine H2-receptor antagonists. Br J Pharmacol 1988;94:264–74.
4. Buschauer A. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. J Med Chem 1989;32:1963–70.
5. Morsdorf P, Engler H, Schickaneder H, Buschauer A, Schunack W, Baumann G. Cardiohistaminergics: New developments in histamine H2 agonists. Drugs Fut 1990;15:919–33.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献